DrugPatentWatch Database Preview
AUSTEDO Drug Profile
Which patents cover Austedo, and what generic alternatives are available?
This drug has twenty-nine patent family members in eleven countries.
The generic ingredient in AUSTEDO is deutetrabenazine. One supplier is listed for this compound. Additional details are available on the deutetrabenazine profile page.
Summary for AUSTEDO
| International Patents: | 29 |
| US Patents: | 5 |
| Applicants: | 1 |
| NDAs: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 8 |
| Patent Applications: | 8 |
| Drug Prices: | see details |
| DailyMed Link: | AUSTEDO at DailyMed |
Synonyms for AUSTEDO
| (3R,11bR)-3-(2-methylpropyl)-9,10-bis(trideuteriomethoxy)-1,3,4,6,7,11b-hexahydrobenzo[a]quinolizin-2-one |
| (3RS,11Brs)-9,10-di((2H3)methoxy)-3-(2-methylpropyl)-1,3,4,6,7,11b-hexahydro-2H-benzo(a)quinolizin-2-one |
| [2H6]-(+)-Tetrabenazine|||[2H6]-(+)- 9,10-Dimethoxy-1,3R,4,6,7,11bR-hexahydro-3-isobutyl-2H-benzo[a]quinolizin-2-one |
| 1392826-25-3 |
| 2H-Benzo(a)quinolizin-2-one, 1,3,4,6,7,11b-hexahydro-9,10-di(methoxy-d3)-3-(2-methylpropyl)-, (3R,11bR)-rel- |
| CHEMBL3137326 |
| D10701 |
| DB12161 |
| Deutetrabenazine |
| Deutetrabenazine (USAN/INN) |
| Deutetrabenazine [USAN:INN] |
| Dutetrabenazine |
| GTPL8707 |
| HY-B0590S |
| Ro 1-9569 D6 |
| SCHEMBL13321841 |
| SCHEMBL16227993 |
| SCHEMBL16228022 |
| SD 809 |
| SD-809 |
| SD809 |
| Tetrabenazine D6 |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-VFJJUKLQSA-N |
| UNII-P341G6W9NB component MKJIEFSOBYUXJB-WEZHFFAMSA-N |
US Patents and Regulatory Information for AUSTEDO
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-001 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | Y | Y | ➤ Sign Up | ||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-002 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-003 | Apr 3, 2017 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | Y | ➤ Sign Up | |||
| Teva Branded Pharm | AUSTEDO | deutetrabenazine | TABLET;ORAL | 208082-001 | Apr 3, 2017 | RX | Yes | No | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
Non-Orange Book US Patents for AUSTEDO
For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.
The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.
| Patent No. | Title | Estimated Patent Expiration |
|---|---|---|
| 9,346,800 | Formulations pharmacokinetics of deuterated benzoquinoline inhibitors of vesicular monoamine transporter 2 | ➤ Sign Up |
| Patent No. | Title | Estimated Patent Expiration |
International Patents for AUSTEDO
| Country | Document Number | Estimated Expiration |
|---|---|---|
| World Intellectual Property Organization (WIPO) | 2010044981 | ➤ Sign Up |
| Spain | 2563820 | ➤ Sign Up |
| China | 104311552 | ➤ Sign Up |
| Canada | 2883641 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
